# Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis

> **NCT06164093** · NA · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 12 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **OTHER:** RNA sequencing is performed on the remaining LPCs
- **OTHER:** Immunofluorescence staining is performed in the surgically resected lung tissue sections

## Key facts

- **NCT ID:** NCT06164093
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-12
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164093, "Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06164093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*